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INTRODUCTION
The p21-activated kinases (Paks), an evolutionarily conserved family of serine/threonine kinases, are important for a variety of cellular functions including cell morphogenesis, cell motility, cell survival, angiogenesis and mitosis (1, 2) . Pak1 was identified as one of the targets of the activated Rho GTPases Cdc42 and Rac1, which stimulate Pak autophosphorylation and activity (3) . Stimulation of Pak1 activity results in several phenotypic changes reminiscent of those produced by Cdc42 and Rac1 (4) (5) (6) (7) . Pak1 is widely expressed in numerous tissues and is activated by a number of polypeptide factors and extracellular signals in both a GTPase-dependent (via Rac1 or Cdc42) and GTPase-independent manner via its localization to membrane/focal adhesion (8) (9) (10) . Paks are also activated by lipids (11) , tyrosine kinases (12, 13) , novel substrates such as filamin (2) , and G-proteins (14) . Some effects of Pak1 on the actin cytoskeleton appear to be independent of Pak1 kinase activity but dependent on protein-protein interactions (4, 18) .
GST-Pak1 enzyme, 10 µCi of γ-32 P-ATP, and 25 µM cold ATP (2) . In some experiments, DIC
immunoprecipitates were used as a substrate in lieu of myelin basic protein.
Immunofluorescence and confocal studies⎯The cellular location of proteins was determined using indirect immunofluorescence (2) . Briefly, cells grown on glass cover slips were fixed in methanol at -20 0 C for 6 min. Cells were incubated with primary antibodies for 2 hr at room temperature, washed three times with PBS and then incubated with 546Alexa (red)-, 633Alexa
(blue)-, or 488 Alexa (green)-labeled secondary antibodies (Molecular Probes, Orlando, FL).
The DNA dye Topro-3 was used to co-stain the DNA, which gives an emission in the far-red segment of the light spectrum and color-coded in blue (Molecular Probes, Orlando, FL).
Confocal analysis was performed with a Zeiss laser-scanning confocal microscope using established methods of processing of the same section for each detector (the two excitations corresponding to 546 and 488, or 633 nm), comparing the sections pixel by pixel. Quantitation of vesicle-like structure was done in some experiments as following. Ten randomly selected fields were analyzed for each condition. The experiment was repeated twice to three times.
Quantitation of vesicles formation was done using the following scoring system. -, cells containing 0-9 vesicles; +, cells containing 10-20 vesicles; and ++, cells containing >20
vesicles.
RESULTS and DISCUSSION
Emerging data suggest that the functions of DLC1 are regulated by its phosphorylation on Ser88 by its upstream kinase Pak1 that also interacts with the penultimate C-terminal 19 amino acids of DLC1 (37) . Since DLC1 was shown to be an essential component of dynein motors (31,32), we reasoned that the process of macropinocytosis might utilize cellular motor.
To explore the potential role of DLC1-Pak1 pathway in the process of macropinocytosis, we asked whether DLC1 (and also Pak1) co-localizes with macropinocytosis markers. Consistent with the earlier findings (25), we found Pak1 colocalization with detectable endocytosed FITCdextran ( Fig. 1a and 1b) and also with endocytosed lucifer yellow (Fig. 1c) , the two commonly used markers of macropinoctosis, in NIH3T3 cells pretreated with either lysophosphatidate (LPA) or serum for 30 min using scanning confocal microscopy. To show the association of DLC1 with macropinocytotic markers, NIH3T3 cells transfected with red fluorescent protein (RFP) tagged-DLC1 were treated with LPA for 30 min in the presence of FITC-dextran. The colocalization of RFP-DLC1 (red) with dextran (green) can be seen as yellow color in merged images (Fig. 1d) . Similarly, we further examined the colocalization of DLC1 with macropinocytic markers and found that RFP-DLC1 was colocalized with FITC-dextran in more than 85% of transfected MCF-7 breast cancer cells stimulated with serum ( Fig. 1e) , suggesting a role of DLC1 in macropinocytosis of stimulated epithelial cells. The co-localization of Pak1 with DLC1 in breast cancer cells ZR75 stimulated with serum ( Fig. 1f) indicated the potential regulatory role of DLC1-Pak1 pathway in the process of macropinocytosis.
In order to clarify the role of DLC1 in macropinocytosis, using ZR75 breast cancer cell line, we generated two stable clones expressing either RFP vector only or RFP-DLC1. We found that RFP-DLC1 clone is much more active in uptaking FITC-dextran and also RFP-DLC1 colocalizes with FITC-dextran upon epidermal growth factor (EGF) treatment (Fig. 2a) . Fig. 6a) to facilitate entry into cells (42) . To detect the cellular uptake of this peptide, it was biotinated at the N-terminus. Initially, we used in vitro kinase assays to determine whether the DLC1 peptide interferes with Pak1 phosphorylation of wild-type DLC1. Addition of DLC1
peptide inhibited Pak1-mediated phosphorylation of wild-type DLC1 in a dose-dependent manner, whereas control TAT peptide had no significant effect (Fig. 6b) . Pak1 also efficiently phosphorylated the synthetic DLC1 C-terminal peptide in in vitro kinase assays (Fig. 6c) . TAT-DLC1 peptide disrupted the Pak1-DLC1 complex formation in GST-pull down assay (Fig. 6d) .
These results suggested that the DLC1 peptide we synthesized contained the Pak1-binding region and phosphorylation site.
Next we visualized the entry of DLC1 peptide into the cells and determined its colocalization with Pak1. Biotin labeled-DLC1 peptide was added into the medium of NIH3T3 cells, and 60 min later, cells were fixed and costained for biotin with streptavidin (red) and endogenous Pak1 (blue). The DLC1 peptide efficiently entered cells ( Fig. 7a and b) and colocalized with endogenous Pak1 (Fig. 7a) . Confocal analysis revealed that DLC1 peptide treatment prevented interaction of Pak1 with dynein complex (data not shown). We next tested whether the DLC1 peptide would inhibit macropinocytosis by interfering Pak1-DLC1
interaction. NIH3T3 cells were stimulated with 10% serum to accelerate the process of macropinocytosis. Cells were pretreated with control peptide (Fig. 7c ) or DLC1 peptide ( Fig.   7d ) for 30 min, and then FITC-dextran were added into the medium. Uptake of FITC-dextran by macropinocytosis was analyzed by confocal microscopy. Quantitation of macropinocytosis by counting the cellular uptake of FITC-dextran showed a 75% reduction in bead uptake in DLC1 peptide-treated cells compared to bead uptake in control peptide-treated cells (Fig. 7e ).
Together these results suggested that C-terminal DLC1 peptide is a potent inhibitor of macropinocytosis.
In brief, results presented here suggested that DLC1 regulation by Pak1 might represent an essential step in the process of macropinocytosis. In this study we showed that Pak1 associates with dynein motor and that Pak1-DLC1 interaction starts at the initiation of pinosome formation and persists in early and late endosomes. Pak1 phosphorylation of DLC1 Ability of TAT-DLC peptide to disrupt DLC1-Pak1 complex formation was analyzed by GSTpull down assay, followed by autoradiography. 
